Basilea Pharmaceutica International AG

AMR 2022 Stakeholder Guide

Pharmaceutica International AG

Focus area/active in: Human Health, Therapeutics

Company/Organisation type: Industry

Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with bacterial and fungal infections and cancer. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. We have several preclinical assets in both anti-infectives and cancer in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN).


Follow  us: 

Get in touch!

Please fill out the form below to get in touch with us.

Share this page: